NL-OMON55051已完成2 期
An Open-Label Study Evaluating Anti-Viral Effects of Voclosporin in SARS-CoV-2 Positive Kidney Transplant Recipients - the VOCOVID Study - the VOCOVID Study
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Subjects with a stable kidney transplant taking Tacrolimus and a confirmed
- •diagnosis of SARS-CoV-2 with mild-to-moderate symptoms
排除标准
- •Severe symptoms resulting from SARS-CoV-2 infection requiring positive pressure
- •ventilation at baseline
研究者
相似试验
进行中（未招募）
1 期
Investigation of the antiviral effect of Voclosporine on COVID-19 in renal transplant patientsSARS-CoV-2 infection in Kidney Transplant RecipientsMedDRA version: 23.0Level: PTClassification code 10051905Term: Coronavirus infectionSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 21.1Level: LLTClassification code 10052212Term: Organ transplant NOSSystem Organ Class: 100000004865EUCTR2020-001467-82-NLeiden University Medical Center30
招募中
2 期
An Open-Label Study Evaluating the Antiviral Activity of Tenofovir Disoproxil Fumarate (DF) 300mg in Patients with Chronic Hepatitis B Infection and Persistent Viral Replication after Long-Term Therapy with Adefovir Dipivoxil 10mg DailyHepatitis BACTRN12606000381583Austin Health (investigator initiated)60
进行中（未招募）
1 期
Phase 1/2 study of IMC-I109V in non-cirrhotic HBeAg-negative chronic HBV infectiochronic hepatitis B virus (HBV) infectionMedDRA version: 20.0Level: LLTClassification code 10019182Term: HBVSystem Organ Class: 100000004848MedDRA version: 20.0Level: LLTClassification code 10019743Term: Hepatitis B virus (HBV)System Organ Class: 100000004848EUCTR2019-004212-64-BEImmunocore Ltd108
招募中
1 期
Phase 1/2 study of IMC-I109V in non-cirrhotic HBeAg-negative chronic hepatitis B (HBV) infectioHBeAg-negative chronic HBV infectionInfection - Other infectious diseasesOral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colonACTRN12620000403932Immunocore Ltd80
进行中（未招募）
1 期
Phase 1/2 study of IMC-I109V in non-cirrhotic HBeAg-negative chronic HBV infectioEUCTR2019-004212-64-PLImmunocore Ltd80